Matches in SemOpenAlex for { <https://semopenalex.org/work/W32463445> ?p ?o ?g. }
- W32463445 endingPage "443" @default.
- W32463445 startingPage "438" @default.
- W32463445 abstract "Summary Intra- and postoperative blood loss during open heart surgery is reduced by approximately 50% when aprotinin, a potent inhibitor for plasmin and kallikrein, is administered during surgery. But whether aprotinin increases the risk of thrombotic complications remains controversial. The aim of this study was to evaluate the effects of aprotinin administration on coagulation and fibrinolysis during and after cardiopulmonary bypass (CPB). Thirty patients undergoing CPB were randomly assigned to two comparable groups for a double-blind study (16 patients receiving high-dose aprotinin, 14 patients receiving placebo). Patients’ plasma levels of ATM (thrombin-induced modified antithrombin III), FbDP (fibrin degradation products, D-Dimers), t-PA (tissue-type plasminogen activator) and PAI-1 (plasminogen activator inhibitor type 1) were measured at regular intervals. In both groups, ATM level increased during surgery (from less than 30 to 90-110 ng/ml) and returned to normal 24 h after surgery and remained unchanged thereafter. Aprotinin reduced this increase in ATM levels (p = 0.02 at 30 min after the start of CPB). The FbDP generated during surgery was greatly reduced in the aprotinin group (945 ng/ml) in comparison with the placebo group (1889 ng/ml, p = 0.004). After surgery, FbDP levels decreased in both groups with nadirs at 2nd day (placebo group: 940 ng/ml and aprotinin group: 865 ng/ml) indicating a hypo-fibrinolytic period. Then, the FbDP level in both groups started to increase up to the 9th day, in an identical manner. This postoperative hypofibrinolysis is related to the changes of t-PA and PAI-1 levels: immediately after surgery there was a 2’fold increase in t-PA level and a 4-5 fold increase in PAI-1 level in the two groups. During the following 24 h, t-PA levels decreased in both groups. In contrast, PAI-1 levels in the placebo group during the same time increased sharply to a maximum level (175.7 ng/ml). This further increase did not occur in the aprotinin group although it remained at a high level (79.2 ng/ml). The difference in the increase of PAI-1 between the 2 groups (value at 24 h minus preoperative value: Dl-Tl) was significantly different (p = 0.04). Then t-PA continued to decrease and PAI-1 began to decrease steadily. Total blood loss was significantly reduced by aprotinin therapy (3.06 ml/kg versus 5.86 ml/kg). The present study confirms the inhibitory effects of aprotinin on both fibrinolytic activity and blood coagulation activation during CPB, and reveals an hypofibrinolytic period that lasts 48 h after surgery in both aprotinin and placebo groups. This inhibition of fibrinolysis is apparently associated with high PAI-1 level. The data of this study also show that 2 days after aprotinin therapy, there is no prolonged effect of aprotinin on fibrinolysis. In addition, the lower level of PAI-1 in the aprotinin group after surgery might result from a protection of endothelial cells by aprotinin, suggesting an unexpected benefit of aprotinin therapy." @default.
- W32463445 created "2016-06-24" @default.
- W32463445 creator A5009348332 @default.
- W32463445 creator A5017706342 @default.
- W32463445 creator A5023668461 @default.
- W32463445 creator A5029395200 @default.
- W32463445 creator A5038478468 @default.
- W32463445 creator A5058081105 @default.
- W32463445 creator A5068705382 @default.
- W32463445 creator A5070942445 @default.
- W32463445 creator A5072610830 @default.
- W32463445 date "1994-01-01" @default.
- W32463445 modified "2023-10-18" @default.
- W32463445 title "Postoperative Hemostasis and Fibrinolysis in Patients Undergoing Cardiopulmonary Bypass with or without Aprotinin Therapy" @default.
- W32463445 doi "https://doi.org/10.1055/s-0038-1648886" @default.
- W32463445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7531877" @default.
- W32463445 hasPublicationYear "1994" @default.
- W32463445 type Work @default.
- W32463445 sameAs 32463445 @default.
- W32463445 citedByCount "39" @default.
- W32463445 countsByYear W324634452014 @default.
- W32463445 countsByYear W324634452015 @default.
- W32463445 crossrefType "journal-article" @default.
- W32463445 hasAuthorship W32463445A5009348332 @default.
- W32463445 hasAuthorship W32463445A5017706342 @default.
- W32463445 hasAuthorship W32463445A5023668461 @default.
- W32463445 hasAuthorship W32463445A5029395200 @default.
- W32463445 hasAuthorship W32463445A5038478468 @default.
- W32463445 hasAuthorship W32463445A5058081105 @default.
- W32463445 hasAuthorship W32463445A5068705382 @default.
- W32463445 hasAuthorship W32463445A5070942445 @default.
- W32463445 hasAuthorship W32463445A5072610830 @default.
- W32463445 hasConcept C126322002 @default.
- W32463445 hasConcept C141071460 @default.
- W32463445 hasConcept C142724271 @default.
- W32463445 hasConcept C181199279 @default.
- W32463445 hasConcept C185592680 @default.
- W32463445 hasConcept C203014093 @default.
- W32463445 hasConcept C204787440 @default.
- W32463445 hasConcept C27081682 @default.
- W32463445 hasConcept C2776572282 @default.
- W32463445 hasConcept C2776825266 @default.
- W32463445 hasConcept C2777557582 @default.
- W32463445 hasConcept C2778589496 @default.
- W32463445 hasConcept C2778789114 @default.
- W32463445 hasConcept C2778881276 @default.
- W32463445 hasConcept C2779026020 @default.
- W32463445 hasConcept C2779637338 @default.
- W32463445 hasConcept C2779679481 @default.
- W32463445 hasConcept C2780799893 @default.
- W32463445 hasConcept C2781071845 @default.
- W32463445 hasConcept C2781436528 @default.
- W32463445 hasConcept C2991743468 @default.
- W32463445 hasConcept C42219234 @default.
- W32463445 hasConcept C54173615 @default.
- W32463445 hasConcept C55493867 @default.
- W32463445 hasConcept C71924100 @default.
- W32463445 hasConceptScore W32463445C126322002 @default.
- W32463445 hasConceptScore W32463445C141071460 @default.
- W32463445 hasConceptScore W32463445C142724271 @default.
- W32463445 hasConceptScore W32463445C181199279 @default.
- W32463445 hasConceptScore W32463445C185592680 @default.
- W32463445 hasConceptScore W32463445C203014093 @default.
- W32463445 hasConceptScore W32463445C204787440 @default.
- W32463445 hasConceptScore W32463445C27081682 @default.
- W32463445 hasConceptScore W32463445C2776572282 @default.
- W32463445 hasConceptScore W32463445C2776825266 @default.
- W32463445 hasConceptScore W32463445C2777557582 @default.
- W32463445 hasConceptScore W32463445C2778589496 @default.
- W32463445 hasConceptScore W32463445C2778789114 @default.
- W32463445 hasConceptScore W32463445C2778881276 @default.
- W32463445 hasConceptScore W32463445C2779026020 @default.
- W32463445 hasConceptScore W32463445C2779637338 @default.
- W32463445 hasConceptScore W32463445C2779679481 @default.
- W32463445 hasConceptScore W32463445C2780799893 @default.
- W32463445 hasConceptScore W32463445C2781071845 @default.
- W32463445 hasConceptScore W32463445C2781436528 @default.
- W32463445 hasConceptScore W32463445C2991743468 @default.
- W32463445 hasConceptScore W32463445C42219234 @default.
- W32463445 hasConceptScore W32463445C54173615 @default.
- W32463445 hasConceptScore W32463445C55493867 @default.
- W32463445 hasConceptScore W32463445C71924100 @default.
- W32463445 hasIssue "03" @default.
- W32463445 hasLocation W324634451 @default.
- W32463445 hasLocation W324634452 @default.
- W32463445 hasOpenAccess W32463445 @default.
- W32463445 hasPrimaryLocation W324634451 @default.
- W32463445 hasRelatedWork W2011964132 @default.
- W32463445 hasRelatedWork W202129753 @default.
- W32463445 hasRelatedWork W2042395242 @default.
- W32463445 hasRelatedWork W2091664212 @default.
- W32463445 hasRelatedWork W2103197287 @default.
- W32463445 hasRelatedWork W2128341033 @default.
- W32463445 hasRelatedWork W2150629962 @default.
- W32463445 hasRelatedWork W2322838869 @default.
- W32463445 hasRelatedWork W4232915482 @default.
- W32463445 hasRelatedWork W67444046 @default.
- W32463445 hasVolume "72" @default.